Section
Equities, indexes, earnings, and the moves that reset portfolios.
SK Biopharmaceuticals shares swung double digits after European regulators opened a monotherapy label window for cenobamate tablets in focal epilepsy, setting a December committee date investors are already modeling.
LG Energy Solution raised cathode shipment guidance for U.S. battery plants after Treasury auditors signed off on IRA foreign-entity rules for its Michigan and Tennessee cathode lines, lifting Kosdaq sentiment on Friday.
A lingering EMA information request on a partnered biosimilar dossier pushes a European distributor’s revenue guide from autumn launches into winter, Celltrion told Seoul analysts.
Hanmi Semiconductor’s order book for HBM bonding tools is swelling as an Ulsan backend hub stages fluxless and hybrid bonder installs ahead of HBM4 ramp talks with memory makers.
Samsung Biologics shares climbed after the CDMO confirmed renewal talks with a top-tier U.S. client on Songdo capacity running through 2029, extending a order book that already cleared 5 trillion won this year.
The Kospi gave back part of its record run as a firmer dollar clipped export margins for Samsung Electronics and SK hynix, with foreign funds trimming buys ahead of Seoul’s long Chuseok weekend.
